Moesges, Ralph, Lee, Dennis Lip Yen, Abong, Jovilia, Siasoco, Bella, Chow, Steven K. W., Leong, Jern-Lin, Singh, Harvinder, Kuljit, S. and Campomanes, Benjamin (2016). Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement. Asia Pac. Allergy, 6 (1). S. 56 - 67. SEOUL: ASIA PACIFIC ASSOC ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY. ISSN 2233-8268

Full text not available from this repository.

Abstract

The prevalence of allergic diseases is increasing globally, most particularly in middle-to low-income countries. This article examines the burden of allergic rhinitis and chronic urticaria in the Asia-Pacific region, unmet clinical needs, and the potential role of bilastine in the management of these conditions. An International Advisory Group meeting was convened in association with the Asian Pacific Society of Respirology Annual Congress in November 2014, followed by a literature review, and consensus-based outcomes from the meeting and literature review are described. Regional estimates of the prevalence of allergic rhinitis range from 10% to 50%, while little is known regarding the burden of urticaria in the Asia-Pacific region. A survey of allergy patients in the region identified fast, complete, and long-lasting symptom relief as the medication attributes most important to patients. International treatment guidelines for allergic rhinitis and urticaria advocate the first-line use of second-generation, no-sedating H-1-antihistamines, such as bilastine, over their first-generation counterparts and a range of these agents are available to Asia-Pacific patients. The newer agents possess many of the properties of an ideal antihistamine (once daily administration, rapid and complete symptom relief, limited potential for drug-drug interactions, minimal side effects). The burgeoning prevalence of allergic diseases in the Asia-Pacific region and the uncontrolled symptoms that these patients experience demand a new antihistamine that offers the highest number of positive features according to the international guidelines.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Moesges, RalphUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lee, Dennis Lip YenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Abong, JoviliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Siasoco, BellaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chow, Steven K. W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leong, Jern-LinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Singh, HarvinderUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kuljit, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Campomanes, BenjaminUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-287838
DOI: 10.5415/apallergy.2016.6.1.56
Journal or Publication Title: Asia Pac. Allergy
Volume: 6
Number: 1
Page Range: S. 56 - 67
Date: 2016
Publisher: ASIA PACIFIC ASSOC ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY
Place of Publication: SEOUL
ISSN: 2233-8268
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CHRONIC IDIOPATHIC URTICARIA; QUALITY-OF-LIFE; DOUBLE-BLIND; ASTHMA ARIA; 20 MG; HEALTHY-VOLUNTEERS; TIME TRENDS; PHASE-III; PREVALENCE; DISEASESMultiple languages
AllergyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/28783

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item